磁振造影造影劑市場－全球產業規模、佔有率、趨勢、機會和預測，依產品、類型、應用、最終用途、地區和競爭格局分類，2021-2031年預測

全球磁振造影（MRI）造影劑市場規模將從2025年的23.8億美元成長至2031年的35.4億美元，複合年成長率（CAGR）為6.84%。磁振造影（MRI）造影劑是一種特殊的化學物質，主要以钆為基礎，透過靜脈注射給藥，以增強診斷掃描過程中體內結構的顯影效果。這些造影劑能夠改變附近水分子的磁性，進而提高影像清晰度，有助於檢測腫瘤、血管異常和神經系統疾病。

主要市場促進因素

政府對診斷影像設施的策略性投資，透過資助醫療基礎設施現代化和擴大患者獲得先進掃描服務的機會，顯著促進了市場成長。世界各國政府都在撥出大量預算，以縮短診斷等待時間，並在醫療資源匱乏的地區安裝最先進的磁振造影系統。

主要市場挑戰

長期在體內組織中滯留钆的安全隱患是限制全球磁振造影造影劑市場發展的主要因素。這種擔憂促使監管機構採取了嚴格的干涉措施，導致更嚴格的給藥方案，從而直接降低了增強磁振造影檢查的頻率和效率。

主要市場趨勢

人工智慧在低劑量造影劑最佳化的應用正在革新市場，它能夠以顯著減少的造影劑用量實現診斷級成像。這一趨勢利用深度學習演算法，從低劑量採集的影像中合成高解析度影像，有效解決了钆滯留這一關鍵安全隱患，從而有效地將影像清晰度與注射顯影劑的用量解耦。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球磁振造影造影劑市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 副產物（超順磁性試劑、順磁性試劑）
  • 按類型（臨床、臨床前）
  • 依應用領域（胃腸道、靜脈注射、肝膽、神經影像、其他）
  • 依最終用途（醫院、影像中心）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美MRI造影劑市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲MRI造影劑市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區磁振造影顯影劑市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲MRI造影劑市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲MRI造影劑市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章：全球磁振造影造影劑市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• GE Healthcare Inc
• Bayer AG
• Guerbet GmbH
• Bracco Imaging Spa
• Vitalquan, LLC
• Miltenyi Biotec BV & Co. Kg

第16章：策略建議

第17章調查會社について,免責事項

The Global MRI Contrast Media Agents Market will grow from USD 2.38 Billion in 2025 to USD 3.54 Billion by 2031 at a 6.84% CAGR. Magnetic Resonance Imaging (MRI) contrast media agents are specialized chemical substances, predominantly gadolinium-based, administered intravenously to enhance the visualization of internal body structures during diagnostic scans. These agents alter the magnetic properties of nearby water molecules to improve image clarity, facilitating the detection of tumors, vascular abnormalities, and neurological conditions.

Key Market Drivers

Strategic Government Investments in Diagnostic Imaging Facilities are significantly catalyzing market growth by funding the modernization of healthcare infrastructure and expanding patient access to advanced scans. Governments worldwide are allocating substantial budgets to reduce diagnostic wait times and install state-of-the-art MRI systems in underserved regions. This financial support directly translates into increased procurement of contrast media as new facilities become operational and scan volumes rise.

Key Market Challenges

Safety concerns regarding the long-term retention of gadolinium in body tissues constitute a primary restraint on the Global MRI Contrast Media Agents Market. This apprehension has necessitated rigorous regulatory interventions, leading to stricter administration protocols that directly reduce the frequency and efficiency of contrast-enhanced procedures. When regulatory bodies mandate extensive pre-screening for renal function or impose heightened safety warnings, imaging facilities face operational bottlenecks that decrease patient throughput.

Key Market Trends

Integration of AI for Low-Dose Contrast Optimization is revolutionizing the market by enabling diagnostic-quality imaging with significantly reduced volumes of contrast media. This trend addresses critical safety concerns regarding gadolinium retention by utilizing deep learning algorithms to synthesize high-resolution images from low-dose acquisitions, effectively decoupling image clarity from the volume of injected agent. This technological synergy not only mitigates potential toxicity risks for patients but also reduces consumable costs for healthcare facilities, driving the adoption of AI-enhanced radiology workflows.

Key Market Players

• GE Healthcare Inc
• Bayer AG
• Guerbet GmbH
• Bracco Imaging Spa
• Vitalquan, LLC
• Miltenyi Biotec B.V. & Co. Kg

Report Scope:

In this report, the Global MRI Contrast Media Agents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

MRI Contrast Media Agents Market, By Products:

• Superparamagnetic agents
• Paramagnetic agents

MRI Contrast Media Agents Market, By Type:

• Clinical
• Preclinical

MRI Contrast Media Agents Market, By Application:

• Gastrointestinal
• Intravenous
• Hepatobiliary
• Neurological Imaging
• Others

MRI Contrast Media Agents Market, By End Use:

• Hospitals
• Imaging Centers

MRI Contrast Media Agents Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global MRI Contrast Media Agents Market.

Available Customizations:

Global MRI Contrast Media Agents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global MRI Contrast Media Agents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Products (Superparamagnetic agents, Paramagnetic agents)
  • 5.2.2. By Type (Clinical, Preclinical)
  • 5.2.3. By Application (Gastrointestinal, Intravenous, Hepatobiliary, Neurological Imaging, Others)
  • 5.2.4. By End Use (Hospitals, Imaging Centers)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America MRI Contrast Media Agents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Products
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States MRI Contrast Media Agents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Products
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada MRI Contrast Media Agents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Products
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico MRI Contrast Media Agents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Products
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End Use

7. Europe MRI Contrast Media Agents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Products
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany MRI Contrast Media Agents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Products
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End Use
  • 7.3.2. France MRI Contrast Media Agents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Products
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom MRI Contrast Media Agents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Products
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy MRI Contrast Media Agents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Products
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain MRI Contrast Media Agents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Products
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End Use

8. Asia Pacific MRI Contrast Media Agents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Products
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China MRI Contrast Media Agents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Products
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End Use
  • 8.3.2. India MRI Contrast Media Agents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Products
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan MRI Contrast Media Agents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Products
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Korea MRI Contrast Media Agents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Products
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia MRI Contrast Media Agents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Products
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End Use

9. Middle East & Africa MRI Contrast Media Agents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Products
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia MRI Contrast Media Agents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Products
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End Use
  • 9.3.2. UAE MRI Contrast Media Agents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Products
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End Use
  • 9.3.3. South Africa MRI Contrast Media Agents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Products
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End Use

10. South America MRI Contrast Media Agents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Products
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil MRI Contrast Media Agents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Products
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End Use
  • 10.3.2. Colombia MRI Contrast Media Agents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Products
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End Use
  • 10.3.3. Argentina MRI Contrast Media Agents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Products
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global MRI Contrast Media Agents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. GE Healthcare Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bayer AG
• 15.3. Guerbet GmbH
• 15.4. Bracco Imaging Spa
• 15.5. Vitalquan, LLC
• 15.6. Miltenyi Biotec B.V. & Co. Kg

16. Strategic Recommendations

17. About Us & Disclaimer